Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07010315
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Cognitive Testing — BEHAVIORALGiven by Survey and one-on one interviews
- Usability Testing — BEHAVIORALGiven by surveys and one-on-one interview.
Study Details
To develop and test liver cancer prevention educational material.
Key Dates
- Start date
- May 1, 2025
- Status verified
- Mar 2026
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 40 participants (estimated)
Arms
- Arm: Cognitive Interviews (English and Spanish)Participants that agree to this part of the study will be asked to view patient education materials about liver cancer, complete a demographic survey, and do an interview one-on-one either online via Zoom, over the phone, or in person at HOPE Clinic.
- Arm: Usability Testing (English and Spanish)Participants will be asked to complete a pre-survey, navigate a liver cancer education website, provide their feedback and impressions, and complete a post- survey.
Primary Outcome Measure
Cognitive Testing [ Time Frame: Up to 1.5 hours ]
Central Contacts
- Jessica Hwang, MD, MPH(346) 720-7352
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | Jessica Hwang, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania
- Checkpoint Inhibition In Pediatric Hepatocellular CarcinomaPHASE2 · Recruiting · Allison O'Neill, MD · San Francisco, California
- Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsPHASE1 · Recruiting · Baylor College of Medicine · Houston, Texas
- Multi-analyte Blood Test Clinical TrialRecruiting · Helio Genomics · Mission Hills, California